Evidence map›Paper›PMID 32533836›Full record

ArticleFEMS yeast research2020

Promoters for lipogenesis-specific downregulation in Yarrowia lipolytica.

Annapurna Kamineni, Shuyan Chen, Gamuchirai Chifamba, Vasiliki Tsakraklides

Open access · hybridAbstract read
In one paragraph

Article in FEMS yeast research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. A review of synthetic biology tools in Yarrowia lipolytica.World journal of microbiology & biotechnology · 2023
    Review
  2. EngineeringSynthetic and systems biotechnology · 2022
    Review
  3. Journal of fungi (Basel, Switzerland) · 2021
    Review
  4. Review
  5. High-performance biological treatment of tuna wash processing wastewater using Yarrowia lipolytica.Environmental science and pollution research international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Annapurna KamineniNovogy, Inc., 85 Bolton Street, Cambridge MA 02140, USA.
Shuyan ChenNovogy, Inc., 85 Bolton Street, Cambridge MA 02140, USA.
Gamuchirai ChifambaNovogy, Inc., 85 Bolton Street, Cambridge MA 02140, USA.
Vasiliki TsakraklidesNovogy, Inc., 85 Bolton Street, Cambridge MA 02140, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yarrowia lipolytica is a non-conventional yeast with potential applications in the biofuel and biochemical industries. It is an oleaginous yeast that accumulates lipids when it encounters nutrient limitation in the presence of excess carbon. Its molecular toolbox includes promoters for robust constitutive expression, regulated expression through the addition of media components and inducible expression during lipid accumulation. To date, no promoters have been identified that lead to downregulation at the transition from growth to lipid accumulation. We identified four native Y. lipolytica promoters that downregulate the expression of genes at this natural transition. Using the fatty acid desaturase genes FAD2 and OLE1 as reporter genes for these promoters, we correlated repression of desaturase transcript levels with a reduction of desaturated fatty acids at the transition to lipid accumulation. These promoters can restrict to the growth phase an essential or favorable activity that is undesirable during lipid accumulation under traditional fermentation conditions without media additions. This expression pattern results in lipogenesis phase-specific changes that could be useful in applications relating to optimizing lipid yield and composition.

Indexed as

LipogenesisPromoter Regions, GeneticDown-RegulationFatty Acid DesaturasesGene Expression Regulation, FungalGenes, FungalGenes, ReporterYarrowiaFatty Acid Desaturasesexpressionlipidregulated promotersrepressionYarrowia lipolytica

Identifiers

PMID32533836
PMCPMC7335367
OpenAlexW3035278817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.